Behind the Balance Sheet

Behind the Balance Sheet

Share this post

Behind the Balance Sheet
Behind the Balance Sheet
Quality Compounders You Can’t Miss: 7 More Elite Growth Picks Analysed

Quality Compounders You Can’t Miss: 7 More Elite Growth Picks Analysed

Including my biggest position and a Mag 7 stock I am trimming, but perhaps not enough.

Stephen Clapham's avatar
Stephen Clapham
Oct 20, 2024
∙ Paid
9

Share this post

Behind the Balance Sheet
Behind the Balance Sheet
Quality Compounders You Can’t Miss: 7 More Elite Growth Picks Analysed
Share

This is the third in a series of reports from the Quality-Growth conference in London. The past two have looked at the first half of the stocks recommended by the dozen quality professional investors and this week we continue with the first half of the second half.

I have done this in chronological order of presenter rather than my favourites, but I highlight which of the recommendations I have liked – one is my largest position - and which I didn’t (2 to date and more today). The quality of the ideas is pretty good and I am usually quite a critical judge.

Plenty of you have liked the idea and upgraded to a paid subscription and I would urge more of you to follow. I bumped into one manager of a £100m+ fund last week who said oh I must upgrade, recognising that he might get some decent ideas. He has done so, is surfing the back catalogue and asking why didn’t I do this before?

Where else can you get such a large crop of ideas (28 from this conference alone) from top investors? And for just $20/mth?


We have two training programmes coming up which you should be aware of:

October 21 - the Forensic Analysis Bootcamp starts. Improve your analytical skills by learning how to be faster and more effective at analysing financial data and valuing businesses. This is a Zoom-based course over 8 weeks and anyone can participate.

November 13 - our Forensic Course is open to analysts in New York City. It’s an all day event and we have multiple signups already. People are flying to New York to take this course, although it’s easier if you are local. This is a one-off.

Book now, this is your last chance for the bootcamp and New York places are limited.


The presenters at The Quality-Growth Conference 2024 were:

Nick Train, PM & Co-founder, Lindsell Train

Rebecca Irwin, Global Equity PM, Jennison Associates

Christopher Rossbach, Co-founder and Manageiing Partner and CIO, J Stern &Co

Laure Negiar, Global Equity PM, Comgest

Andrew Brenton, Co-Founder and CEO Turtle Creek Asset Management

William Low, Global Equity PM, Nikko Asset Management

Kinal Desai, Co-PM Global EM Equities, GIB Asset Management

Stephen Yiu, Founder and CIO Bluw Whale Capital

Ronald Chan, Founder and CIO Chartwell Capital

Angela Wu, Analyst, Artisan Partners

Alx Lee, Principal and PM Sustainable Gorwth Advisers

Stephanie Niven, co-PM Global Sustainable Equity, 91 Asset Management

James Anderson, Managing Partner, Lingotto Investment Management

Before premium subscribers read on for another bumper pack of quality growth stocks, and a discussion of two of my largest holdings, a quick mea culpa.  I advise my students that it’s quicker to read things on paper and to consume the FT or Wall Street Journal in newspaper form (less noise, easier to identify the key stories) – the younger ones shake their head sadly.

I also advise taking notes with a pen and notebook (or in the office, I use a side of A4 which I then scan), partly because my typing is so bad, but also because I think you are more likely to remember if you write. Of course, this assumes you can read your own writing. In last week’s article, I wrote “…..35 Bio Inc in China (I may well have this wrong, as 35Bio appears to be a young UK company).”

Thanks to Ali, a subscriber who explained that the company is 3S Bio not 35 Bio – I cannot read my own handwriting! Sorry. I feel stupid, but I shall be sticking to my strategy of reading on paper wherever possible and writing things down when taking notes. Lots of academic work supports this – it’s not just my age.

Now I have confessed publicly, premium subscribers can read on to find out

  • why 3S Bio was relevant

  • why I am having angst about whether to trim further one of my larger positions, which one presenter described as “gruesome”

  • the stock that the same presenter and I agree on

  • and 7 more quality growth names  

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Behind the Balance Sheet Ltd
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share